Guardant Health
GH
#1450
Rank
โ‚น1.475 T
Marketcap
โ‚น11,130
Share price
17.09%
Change (1 day)
225.31%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Revenue for Guardant Health (GH)

Revenue in 2026 (TTM): โ‚น96.90 Billion

According to Guardant Health 's latest financial reports the company's current revenue (TTM ) is โ‚น104.57 Billion. In 2025 the company made a revenue of โ‚น88.15 Billion an increase over the revenue in the year 2024 that were of โ‚น63.39 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Guardant Health from 2018 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น96.90 B9.92%
2025 โ‚น88.15 B39.05%
2024 โ‚น63.39 B35.04%
2023 โ‚น46.94 B26.21%
2022 โ‚น37.19 B33.76%
2021 โ‚น27.81 B32.63%
2020 โ‚น20.96 B37.17%
2019 โ‚น15.28 B141.21%
2018 โ‚น6.33 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Neogen
NEOG
โ‚น84.27 B-19.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
โ‚น242.11 B 131.52%๐Ÿ‡บ๐Ÿ‡ธ USA